SOW
PHAT icon

State of Wyoming’s Phathom Pharmaceuticals PHAT Stock Holding History

State of Wyoming’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191K Buy
17,639
+12,703
+257% +$145K 0.02% 1042
2026
Q1 		$54.8K Buy
+4,936
New +$62.3K 0.01% 1523

Other funds holding PHAT

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

State of Wyoming's PHAT Position: Q2 2026 in Review

State of Wyoming increased its Phathom Pharmaceuticals (PHAT) stake by 257% in Q2 2026, buying an estimated $145K and bringing the position to 17,639 shares worth $191K. The position accounts for 0.02% of the portfolio, ranked #1042.

State of Wyoming first reported a position in PHAT in Q1 2026 and has held it in 2 quarters since. 161 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • State of Wyoming held 17,639 shares of Phathom Pharmaceuticals worth $191K as of Q2 2026.
  • State of Wyoming bought 12,703 Phathom Pharmaceuticals shares in Q2 2026, an estimated $145K.
  • Phathom Pharmaceuticals made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #1042 holding.
  • State of Wyoming first reported a position in Phathom Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.